Back
Spero Therapeutics Vs. Johnson & Johnson Industry Stock Comparison
Sell
13
SPRO
Spero Therapeutics
Last Price:
1.13
Seasonality Move:
7.16%
Sell
47
JNJ
Johnson & Johnson
Last Price:
155.38
Seasonality Move:
0.86%
Sell
13
Spero Therapeutics (SPRO)
is a Sell
Is Spero Therapeutics a Buy, Sell or Hold?
- The current Spero Therapeutics [SPRO] share price is $1.13. The Score for SPRO is 13, which is 74% below its historic median score of 50, and infers higher risk than normal.
- SPRO is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
47
Johnson & Johnson (JNJ)
is a Sell
Is Johnson & Johnson a Buy, Sell or Hold?
- The current Johnson & Johnson [JNJ] share price is $154.52. The Score for JNJ is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
- JNJ is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
SPRO Stock Price Chart
What is Spero Therapeutics's stock price today?
-
The Spero Therapeutics share price today is $1.13
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SPRO is experiencing slight selling pressure.
JNJ Stock Price Chart
What is Johnson & Johnson's stock price today?
-
The Johnson & Johnson share price today is $154.52
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and JNJ is experiencing slight buying pressure.
SPRO Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.04 | Sell |
| Relative Strength Index (14 RSI): | 35.13 | Sell |
| Chaikin Money Flow: | -27946 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.18 - 1.32) | Sell |
| Bollinger Bands (100): | (1.24 - 1.38) | Sell |
JNJ Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.66 | Sell |
| Relative Strength Index (14 RSI): | 41.93 | Sell |
| Chaikin Money Flow: | 1711044 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (153.5 - 160.74) | Sell |
| Bollinger Bands (100): | (154.81 - 164.53) | Sell |
SPRO Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.16 | Sell |
| 20-day SMA: | 1.24 | Sell |
| 50-day SMA: | 1.27 | Sell |
| 200-day SMA: | 1.43 | Sell |
| 8-day EMA: | 1.18 | Sell |
| 20-day EMA: | 1.22 | Sell |
| 50-day EMA: | 1.26 | Sell |
| 200-day EMA: | 1.37 | Sell |
JNJ Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 154.48 | Buy |
| 20-day SMA: | 155.8 | Sell |
| 50-day SMA: | 159.78 | Sell |
| 200-day SMA: | 155.79 | Sell |
| 8-day EMA: | 154.75 | Sell |
| 20-day EMA: | 156 | Sell |
| 50-day EMA: | 158.25 | Sell |
| 200-day EMA: | 157.53 | Sell |
Spero Therapeutics Earnings Growth & SPRO Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.22 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.55 per share, and an increase next year of $0.58 per share.
Johnson & Johnson Earnings Growth & JNJ Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.48 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.04 per share, and an increase next year of $0.67 per share.
Spero Therapeutics Technical Analysis
| Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | Nov 25 | Nov 26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | 25 | 26 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Johnson & Johnson Technical Analysis
| Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | Nov 25 | Nov 26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | 25 | 26 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||